A phase II double-blind, randomized clinical trial assessing the tolerability of two different ratios of cannabis in patients with glioblastoma multiforme (GBM).

Overview of attention for article published in Journal of Clinical Oncology, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 19 X users

Readers on

mendeley: 44 Mendeley

So far, Altmetric has seen 26 X posts from 19 X users, with an upper bound of 206,633 followers.

Results from a 2020 clinical trial showed that a single nightly dose of THC-containing cannabis was well tolerated in patients with glioblastoma multiforme (GBM) and significantly improved sleep and functional wellbeing and quality of life. https://t.c…

RT @GreenleafMed: Cannabis may have benefits in the treatment of cancer-related symptoms. The results from a clinical trial concluded that…

Cannabis may have benefits in the treatment of cancer-related symptoms. The results from a clinical trial concluded that THC significantly improved sleep and functional wellbeing in GBM patients. Source: https://t.co/df8WyNzVq2 #GlioblastomaAwareness…

RT @cannaworldsite: A phase II double-blind, randomized clinical trial assessing the tolerability of two different ratios of cannabis in pa…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 22 additional X posts.